SPA17 and neoplasm: In addition, FSIP1 can bind to and activate cancer/testis antigen proteins (including CABYR, SPA17, AKAP3, AKAP4, and ROPN1) in the fibrous sheath in tumor cells, in turn promoting cancer progression [3, 6–8].